Center for Cancer Immunotherapy and Immunobiology

Associate Professor Yuki Sato(Hakubi)
Multi-Omics Platform

Education

  • 2011-2015: Ph.D. in Medicine, Department of Nephrology, Graduate School of Medicine,  Kyoto University
  • 2000-2006: MD, Department of Medicine, Ehime University

Professional Experiences

  • 2025 Oct-: Program-Specific Associate Professor, Hakubi Center for Advanced Research, Kyoto University / Center for Cancer Immunotherapy and Immunobiology, Department of Multiomics platform, Graduate School of Medicine, Kyoto University
  • 2023-2025 Sep: Assistant Professor, Department of Medicine, Mayo Clinic, MN, USA
  • 2021-2023: Research Fellow, Department of Medicine/Immunology, Mayo Clinic College of Medicine and Science
  • 2015-2021: Program-specific Assistant Professor, Graduate School of Medicine, Kyoto University
  • 2008-2011: Tazuke Kofukai Foundation, Medical Research Institute, Kitano Hospital, Department of Nephrology (Senior Resident)
  • 2006-2008: Sendai City Hospital (Junior Resident)

Licenses & Certificates

Selected Publications

  1. Yuki Sato. “Immune aging and its implication for age-related disease progression” Physiology 40:363-373, 2025. DOI:10.1152/physiol.00051.2024.
  2. Yuki Sato, Abhinav Jain, Shozo Ohtsuki, Hirohisa Okuyama, Ines Sturmlechner, Yoshinori Takashima, Kevin-Phu C. Le, Melanie C. Bois, Gerald J. Berry, Kenneth J. Warrington1, Jörg J. Goronzy, and Cornelia M. Weyand. “Stem-like CD4+ T cells in perivascular tertiary lymphoid structures sustain autoimmune vasculitis” Sci. Transl. Med. 2023, 15 eadh0380. DOI: 10.1126/scitranslmed.adh0380.
  3. Yuki Sato, Karina Silina, Maries van den Broek, Kiyoshi Hirahara and Motoko Yanagita. “The roles of tertiary lymphoid structures in chronic disease” Nat Rev Nephrol 2023, 19, 525-537. DOI:10.1038/s41581-023-00706-z
  4. Tuantuan Zhao*, Yuki Sato*, Jorg Goronzy, Cornelia M Weyand. “T cell aging associated phenotype (TASP) in autoimmune disease”, Front Aging 2022, 3:867950. (*:co-first author) DOI:10.3389/fragi.2022.867950.
  5. Yuki Sato*, Akiko Oguchi, Yuji Fukushima, Kyoko Masuda, Naoya Toriu, Keisuke Taniguchi, Takahisa Yoshikawa, Xiaotong Cui, Makiko Kondo, Takeshi Hosoi, Shota Komidori, Yoko Shimizu, Harumi Fujita, Li Jiang, Yingvi Kong, Takashi Yamanashi, Jun Seita, Takuya Yamamoto, Shinya Toyokuni, Yoko Hamazaki, Masakazu Hattori, Yasunobu Yoshikai, Peter Boor, Jürgen Floege, Hiroshi Kawamoto, Yasuhiro Murakawa, Nagahiro Minato and Motoko Yanagita*. “CD153-CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury” J Clin Invest 2022;132(2):e146071. (*: corresponding author) DOI:10.1172/JCI146071.
  6. Yu Ho Lee*, Yuki Sato*, Mitsuru Saito, Shingo Fukuma, Masaya Saito, Shigenori Yamamoto, Atsushi Komatsuda, Nobuhiro Fujiyama, Shigeru Satoh, Sang-Ho Lee, Peter Boor, Tomonori Habuchi, Jürgen Floege and Motoko Yanagita. “Advanced tertiary lymphoid tissues in protocol biopsies are associated with progressive graft dysfunction in kidney transplant recipients.” J Am Soc Nephrol 2022, 33,186-200. (*: co-first author) DOI: 10.1681/ASN.2021050715
  7. Yuki Sato, Yu Ho Lee, Keisuke Taniguchi, Takahisa Yoshikawa, Peter Boor, Jürgen Floege, and Motoko Yanagita. “Author’s reply. Advanced tertiary lymphoid tissues in protocol biopsies in kidney transplant recipients: Addressing additional methods to detect intragraft B cells” J Am Soc Nephrol 2022, 33: 868-869. DOI: 10.1681/ASN.2021121588
  8. Yuki Sato*, Masaru Tamura, Motoko Yanagita*. “Tertiary lymphoid tissues: a regional hub for kidney inflammation”, Nephrol Dial Transplant, 2021;37:1-8. (*: corresponding author) DOI:10.1093/ndt/gfab212.
  9. Hiroyuki Arai, Yuki Sato*, Motoko Yanagita*. “Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney”, Immunol Rev, 2021. PMID: 33951198 (*:corresponding author) DOI:10.1111/imr.12969.
  10. Yuki Sato*, Masahiro Takahashi*, Motoko Yanagita. “Pathophysiology of AKI to CKD progression”, Semin Nephrol, 2020;40(2):206-215. (*: co-first author) DOI: 10.1016/j.semnephrol.2020.01.011.
  11. Yuki Sato, Peter Boor, Shingo Fukuma, Barbara M. Klinkhammer, Hironori Haga, Osamu Ogawa, Jürgen Floege and Motoko Yanagita. “Developmental stages of tertiary lymphoid tissue reflect local injury and inflammation in murine and human kidneys” Kidney Int 2020, 98(2),448-463. (Cover picture of the issue) DOI:10.1016/j.kint.2020.02.023.
  12. Jin Nakamura*, Yuki Sato*, Yuichiro Kitai*, Shuichi Wajima, Shinya Yamamoto, Akiko Oguchi, Ryo Yamada, Keiichi Kaneko, Makiko Kondo, Eiichiro Uchino, Junichi Tsuchida, Keita Hirano, Kumar Sharma, Kenji Kohno and Motoko Yanagita. “Myofibroblasts acquire retinoic acid-producing ability during fibroblast-to-myofibroblast transition in kidney disease” Kidney Int 2019 95(3):526-539. (*: co-first author) DOI:10.1016/j.kint.2018.10.017.
  13. Yuki Sato*, Motoko Yanagita*. “The immunology of aging kidney” Nat Rev Nephrol, 15, 625-640, 2019. (*: corresponding author) DOI:10.1038/s41581-019-0185-9
  14. Yuki Sato, Motoko Yanagita. “Functional heterogeneity of resident fibroblasts in the kidney”, Proc Jpn Acad Ser B Phys Biol Sci. 2019;95(8):468-478. DOI:10.2183/pjab.95.033. 
  15. Yuki Sato, Motoko Yanagita. “Immune cells and inflammation in AKI to CKD progression”, Am J Physiol Renal Physiol, 315: F1501-12, 2018. DOI:10.1152/ajprenal.00195.2018. 
  16. Yuki Sato, Motoko Yanagita. “Resident fibroblasts in the kidney: a major driver of fibrosis and inflammation”, Inflammation and Regeneration, 2017 37:17. DOI:10.1186/s41232-017-0048-3.
  17. Yuki Sato, Akiko Mii, Yoko Hamazaki, Harumi Fujita, Hirosuke Nakata, Kyoko Masuda, Shingo Nishiyama, Shinsuke Shibuya, Hironori Haga, Osamu Ogawa, Akira Shimizu, Shuh Narumiya, Tsuneyasu Kaisho, Makoto Arita, Masashi Yanagisawa, Masayuki Miyasaka, Kumar Sharma, Nagahiro Minato, Hiroshi Kawamoto, Motoko Yanagita. “Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney” JCI Insight, 2016;1(11):e87680. (Top-read JCI insight articles of 2016: 6/10th) DOI:10.1172/jci.insight.87680.
  18. Yuki Sato, Motoko Yanagita. “Renal anemia: from incurable to curable” Am J Physiol Renal Physiol, 305(9): F1239-48, 2013. DOI:10.1152/ajprenal.00233.2013.

  

WordPress Lightbox